0
     

Report Added
Report already added
Analgesics in Russia

Analgesics in Russia

Adult combination products - analgesics is seeing the fastest current value sales growth in 2019. These products do not fall under the state’s regulation of unit prices, while other types of analgesics are listed as essential medicines. As the unit prices of adult combination products are not restricted, players are able to reflect their investments in branding, promotion and advertising in the product price. Adult combination products are expected to continue to perform well over the forecast p...

Analgesics in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Analgesics in Russia

Headlines
Prospects
Lack of Price Regulation Fosters Strong Value Growth for Adult Combination Products
Efficacy Over Naturalness for Price-sensitive Consumers of Systemic Analgesics
Weak Control of Rx Medicines Stifles Adult Diclofenac's Performance
Competitive Landscape
Otcpharm Invests in Products and Promotion To Lead the Field
Nurofen Remains Top-of-mind Through Strong Investment in Advertising
Voltaren Emulgel's New Format Is Likely To Stimulate Interest Among Competitors
Category Data
Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024
Executive Summary
Weak Household Budgets Limit Value Sales Development in 2019
Gradual Shift To Generics in A Price-sensitive Environment
Agreements With Pharmacy Chains Offer Key Competitive Edge To Companies
Online Channel Offers Marketing and Sales Opportunities To Players and Retailers
Pockets of Strong Value Growth Despite Stagnating Demand
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019
Market Data
Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources

Report Title: Analgesics in Russia


Your Details
Valid Invalid number

Related Report

SELECT A FORMAT

ADD TO CART BUY NOW